Company: HRTX
Filing Date: 2025-06-18
Form Type: 8-K
Source: 0000950170-25-087555
Chunk: 2

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-06-18
Form: 8-K
Item: Item 5.07
Chunk 2
---
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                           Heron Therapeutics, Inc.                           
  Date: June 17, 2025      /s/ Ira Duarte                                     
                           Ira Duarte                                         
                           Executive Vice President, Chief Financial Officer